Publications

On January 2021, I had co-authors 87 papers published in international peer-reviewed medical and statistical journals. A complete list of my publications is as available as :

https://dial.uclouvain.be/DialExport/Portail?method=bibliography&type=classic&author=Legrand,%20Catherine&sort=documentType&sortType=asc

My publications over the last 5 years are

  • Inference in a survival cure model with mismeasured covariates using a simulation-extrapolation approach. Bertrand A, Legrand C, Carroll R, de Meester C, Van Keilegom I. Biometrika 2017; 104 (1): 31-50. doi: 10.1093/biomet/asw054.
  • Use of the beta-binomial model for central statistical monitoring of multicenter clinical trials. Desmet L, Venet D, Doffagne E, Timmermans C, Legrand C, Burzykowski T, Buyse M. Statistics in Biopharmaceutical Research. 2017; 9(1): 1-11. http://dx.doi.org/10.1080/19466315.2016.1164751.
  • Robustness of estimation methods in a survival cure model with mismeasured covariates. Bertrand A, Legrand C, Léonard D, Van Keilegom I. Computational Statistics & Data Analysis. 2017, Vol. 113, p. 3-18. doi:10.1016/j.csda.2016.11.013. doi:https://doi.org/10.1016/j.csda.2016.11.013.
  • Diagnostic checks in mixture cure models with interval-censoring. Scolas S, Legrand C, Oulhaj A, El Ghouch A. Statistical Methods in Medical Research. 2018 Jul; 27(7):2114-2131. doi: 10.1177/0962280216676502. Epub 2016 Nov 4.
  • Risk classification in life insurance and health insurance: extension to continuous covariates. Denuit M, Legrand C. European Actuarial Journal. 2018; 21: 611-619.
  • The Single-Index/Cox Mixture Cure Model. Amico M, Van Keilegom I, Legrand C. Biometrics 2019; 75, p452-462. doi: 10.1111/biom.12999.
  • A note on tests for relevant differences with extremely large sample sizes. Callegaro A, Ndour C, Aris E, Legrand C. Biometrical Journal. 2019 Jan; 61(1): 162-165. doi: 10.1002/bimj.201800195. Epub 2018 Nov 11.
  • Vertical modeling: analysis of competing risks data with a cure fraction. Nicolaie MA, Taylor JMG, Legrand C. Lifetime Data Anal. 2019 Jan; 25(1): 1-25. doi: 10.1007/s10985-018-9417-8. [Epub ahead of print]
  • Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans. Burny W, Marchant A, Hervé C, Callegaro A, Caubet M, Fissette L, Gheyle L, Legrand C, Ndour C, Tavares da Silva F, van der Most R, Willems F, Didierlaurent AM, Yarzabal J; ECR-008 study group. Vaccine. 2019 Mar; 37(14): 2004-2015. Doi: 10.1002/bimj.201800195.
  • Flexible parametric approach to classical measurement error variance estimation without auxiliary data. Bertrand A, Van Keilegom I, Legrand C. Biometrics. 2019 Mar; 75(1): 297-307. doi: 10.1111/apt.14790.
  • DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk group. Narasimhaiah D, Legrand C, Damotte D, Remark R, Munda, M, De Potter P, Coulie PG, Vikkula M, Godfraind C. Cancer Medicine. 2019 Jun;8(6):3036-3046. doi: 10.1002/cam4.2122.
  • Incidence and risk factors for adverse events during monitored anaesthesia care for gastrointestinal endoscopy in children: A prospective observational study. Najafi N, Veyckemans F, Vanhonacker D, Legrand C, Van de Velde A, Vandenplas Y, Poelaert J.Eur J Anaesthesiol. 2019 Jun;36(6):390-399. doi: 10.1097/EJA.0000000000000995.
  • Joint longitudinal and time-to-event cure models for the assessment of being cured. Barbieri A, Legrand C. Stat Methods Med Res. 2020 Apr;29(4):1256-1270. doi: 10.1177/0962280219853599. Epub 2019 Jun 19.
  • Evaluating case management as a complex intervention: Lessons for the future. Lambert AS, Legrand C, Cès S, Van Durme T, Macq J. PLoS One. 2019 Oct 31;14(10):e0224286. doi: 10.1371/journal.pone.0224286.
  • A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons. Cantagallo E, De Backer M, Kicinski M, Ozenne B, Collette L, Legrand C, Buyse M, Péron J.Biom J. 2020 Sep 16. doi: 10.1002/bimj.201900354. Online ahead of print.
  • Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country. Molenberghs G, Buyse M, Abrams S, Hens N, Beutels P, Faes C, Verbeke G, Van Damme P, Goossens H, Neyens T, Herzog S, Theeten H, Pepermans K, Abad AA, Van Keilegom I, Speybroeck N, Legrand C, De Buyser S, Hulstaert F. Contemp Clin Trials. 2020 Dec;99:106189. doi: 10.1016/j.cct.2020.106189. Epub 2020 Oct 22.
  • Waiting period from diagnosis for mortgage insurance issued to cancer survivors. European Actuarial Journal (2020) Soetewey, A., Legrand, C., Denuit, M., Silversmit G. DOI: 10.1007/s13385-020-00254-x

I’m currently working on the following projects (To be completed):

  • Population stratification based on healthcare trajectory: a tool to study the needs of the elderly that accounts for uncertainty. Lambert AS, Legrand C, Deconinck H, Samadoulougou S, Alvarez L, Macq . Submitted to Health Policy.
  • Using routine database as a tool for systemic reflection on local governance. Lambert AS, Legrand C, Alvarez L, Haakma T, Macq J. Submitted to International Journal of Integrated Care.
  • On the use of Extreme Value Theory for Pairwise Comparisons with Censored Outcomes. Debacker M, Legrand C, Peron J, Lambert A, Buyse M. Submitted to Biometrical Journal.

I have also collaborated on the writing of two book chapters:

  • Algorithm Survival Analysis. Gagliolo M, Legrand C. Invited book chapter, in: T. Bartz-Beielstein et al., eds., Experimental Methods for the Analysis of Optimization Algorithms, 2010, Springer, Berlin.

Recently, I have written a book on survival data analysis, presenting several extensions of the classical survival models:

Advanced Survival Models. Legrand C. Chapman & Hall/CRC Press, 2021.